Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Baradaran

Showing results (581-590 of 707) with videos related to

Pageof 71
Sort By:
Frontiers in Oncology|August 26, 2021
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44<sup>+</sup>CD24<sup>-</sup> Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road AheadMahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 10, 2025
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Experimental and Molecular Pathology|May 1, 2024
Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3<sup>+</sup> T cells from COVID-19 patientsSamaneh Abdolmohammadi-Vahid, Behzad Baradaran, Armin Sadeghi, et al.
Advanced Healthcare Materials|July 13, 2022
Conductive and Semiconductive Nanocomposite-Based Hydrogels for Cardiac Tissue EngineeringSania Ghobadi Alamdari, Abbas Alibakhshi, Miguel de la Guardia, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 12, 2022
Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trialAmir Hossein Faghfouri, Alireza Khabbazi, Behzad Baradaran, et al.
International Immunopharmacology|May 13, 2022
Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trialAmir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 12, 2017
Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expressionNeda Shajari, Sadaf Davudian, Tohid Kazemi, et al.
In Silico Pharmacology|March 8, 2021
Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico studyFateme Sefid, Zahra Payandeh, Ghasem Azamirad, et al.
Molecular Biology Reports|November 18, 2020
siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468)Fatemeh Vahidian, Elham Safarzadeh, Ali Mohammadi, et al.
Iranian Journal of Pharmaceutical Research : IJPR|July 10, 2020
Comparative of <i>in-vitro</i> Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell LineFereydoon Abedi Gaballu, Soheil Abbaspour-Ravasjani, Behzad Mansoori, et al.
Pageof 71

Showing results (581-590 of 707) with videos related to

Sort By:
Pageof 71
Frontiers in Oncology|August 26, 2021
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44<sup>+</sup>CD24<sup>-</sup> Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road AheadMahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 10, 2025
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Experimental and Molecular Pathology|May 1, 2024
Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3<sup>+</sup> T cells from COVID-19 patientsSamaneh Abdolmohammadi-Vahid, Behzad Baradaran, Armin Sadeghi, et al.
Advanced Healthcare Materials|July 13, 2022
Conductive and Semiconductive Nanocomposite-Based Hydrogels for Cardiac Tissue EngineeringSania Ghobadi Alamdari, Abbas Alibakhshi, Miguel de la Guardia, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 12, 2022
Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trialAmir Hossein Faghfouri, Alireza Khabbazi, Behzad Baradaran, et al.
International Immunopharmacology|May 13, 2022
Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trialAmir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 12, 2017
Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expressionNeda Shajari, Sadaf Davudian, Tohid Kazemi, et al.
In Silico Pharmacology|March 8, 2021
Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico studyFateme Sefid, Zahra Payandeh, Ghasem Azamirad, et al.
Molecular Biology Reports|November 18, 2020
siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468)Fatemeh Vahidian, Elham Safarzadeh, Ali Mohammadi, et al.
Iranian Journal of Pharmaceutical Research : IJPR|July 10, 2020
Comparative of <i>in-vitro</i> Evaluation between Erlotinib Loaded Nanostructured Lipid Carriers and Liposomes against A549 Lung Cancer Cell LineFereydoon Abedi Gaballu, Soheil Abbaspour-Ravasjani, Behzad Mansoori, et al.
Pageof 71